Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 112.00 | 126.75 | 0.8836 | 0.8886 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 156.25 | 28.40 | 118.00 | 126.75 | 0.9310 | 0.9348 |
| BT-20 | Linsitinib | 1 | uM | 7 | 156.25 | 28.40 | 135.00 | 126.75 | 1.0651 | 1.0593 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 97.00 | 126.75 | 0.7653 | 0.7669 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 113.00 | 126.75 | 0.8915 | 0.8964 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 156.25 | 28.40 | 55.00 | 126.75 | 0.4339 | 0.3584 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 156.25 | 28.40 | 70.00 | 126.75 | 0.5523 | 0.5190 |
| BT-20 | Lapatinib | 1 | uM | 7 | 156.25 | 28.40 | 147.00 | 126.75 | 1.1598 | 1.1422 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 173.00 | 126.75 | 1.3649 | 1.3101 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 133.00 | 126.75 | 1.0493 | 1.0451 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 78.00 | 126.75 | 0.6154 | 0.5971 |
| BT-20 | Erlotinib | 10 | uM | 7 | 156.25 | 28.40 | 101.00 | 126.75 | 0.7968 | 0.8003 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 262.00 | 126.75 | 2.0671 | 1.7999 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 156.25 | 28.40 | 75.00 | 126.75 | 0.5917 | 0.5683 |
| BT-20 | Lapatinib | 10 | uM | 7 | 156.25 | 28.40 | 71.00 | 126.75 | 0.5602 | 0.5290 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 101.00 | 126.75 | 0.7968 | 0.8003 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 3.00 | 126.75 | 0.0237 | -0.6471 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 4.00 | 277.50 | 0.0144 | -0.9642 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 264.00 | 277.50 | 0.9514 | 0.9076 | |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 312.50 | 133.67 | 266.00 | 277.50 | 0.9586 | 0.9213 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 321.00 | 277.50 | 1.1568 | 1.2964 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 302.00 | 277.50 | 1.0883 | 1.1672 | |
| BT-20 | 17-AAG | 1 | uM | 7 | 312.50 | 133.67 | 141.00 | 277.50 | 0.5081 | 0.0520 |
| BT-20 | Linsitinib | 10 | uM | 7 | 312.50 | 133.67 | 220.00 | 277.50 | 0.7928 | 0.6045 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 312.50 | 133.67 | 130.00 | 277.50 | 0.4685 | -0.0260 |